BioHarvest Sciences (NASDAQ:BHST – Get Free Report) is anticipated to release its earnings data before the market opens on Monday, March 31st. Analysts expect BioHarvest Sciences to post earnings of ($0.12) per share and revenue of $7.24 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.
BioHarvest Sciences Stock Up 1.6 %
BioHarvest Sciences stock opened at $6.55 on Friday. The stock has a market cap of $107.58 million, a price-to-earnings ratio of -5.24 and a beta of 2.27. BioHarvest Sciences has a 52 week low of $6.53 and a 52 week high of $7.38. The stock has a 50-day simple moving average of $5.65.
Analyst Ratings Changes
Several analysts have recently commented on the stock. HC Wainwright initiated coverage on shares of BioHarvest Sciences in a research report on Friday, December 6th. They issued a “buy” rating and a $14.00 price target on the stock. Maxim Group initiated coverage on BioHarvest Sciences in a research note on Wednesday, December 18th. They issued a “buy” rating and a $12.00 target price on the stock.
BioHarvest Sciences Company Profile
BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.
See Also
- Five stocks we like better than BioHarvest Sciences
- Top Stocks Investing in 5G Technology
- MarketBeat Week in Review – 03/24 – 03/28
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.